Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research

Eur Respir J. 2017 Aug 3;50(2):1700983. doi: 10.1183/13993003.00983-2017. Print 2017 Aug.

Authors

Tim Lahm^{1

2

3}, Steven M Kawut⁴

Affiliations

¹ Dept of Medicine; Division of Pulmonary, Critical Care, Occupational and Sleep Medicine, Indiana University School of Medicine, Indianapolis, IN, USA tlahm@iu.edu.
² Dept of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.
³ Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.
⁴ Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

PMID: 28775051
DOI: 10.1183/13993003.00983-2017

No abstract available

Publication types

Editorial
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Estrogens*
Familial Primary Pulmonary Hypertension
Humans
Hypertension, Pulmonary*

Substances

Estrogens